Lonazolac: Difference between revisions
Content deleted Content added
Updating {{drugbox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation ( |
No edit summary |
||
Line 1: | Line 1: | ||
{{ |
{{drugbox |
||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = 13097143QI |
|||
| verifiedrevid = 407618765 |
| verifiedrevid = 407618765 |
||
| IUPAC_name = [3-(4-chlorophenyl)-1-phenyl-1''H''-pyrazol-4-yl]acetic acid |
| IUPAC_name = [3-(4-chlorophenyl)-1-phenyl-1''H''-pyrazol-4-yl]acetic acid |
Revision as of 22:52, 30 June 2011
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
PubChem CID | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.053.428 |
Chemical and physical data | |
Formula | C17H13ClN2O2 |
Molar mass | 312.75032 g/mol g·mol−1 |
(verify) |
Lonazolac is a non-steroidal anti-inflammatory drug.